Drug General Information |
Drug ID |
D0Z2TG
|
Former ID |
DNC008868
|
Drug Name |
PEDUNCULAGIN
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C34H24O22
|
Canonical SMILES |
C1C2C(C3C(C(O2)O)OC(=O)C4=CC(=C(C(=C4C5=C(C(=C(C=C5C(=O<br />)O3)O)O)O)O)O)O)OC(=O)C6=CC(=C(C(=C6C7=C(C(=C(C=C7C(=O)<br />O1)O)O)O)O)O)O
|
InChI |
1S/C34H24O22/c35-10-1-6-15(23(43)19(10)39)16-7(2-11(36)20(40)24(16)44)31(48)54-27-14(5-52-30(6)47)53-34(51)29-28(27)55-32(49)8-3-12(37)21(41)25(45)17(8)18-9(33(50)56-29)4-13(38)22(42)26(18)46/h1-4,14,27-29,34-46,51H,5H2/t14-,27-,28+,29-,34?/m1/s1
|
InChIKey |
IYMHVUYNBVWXKH-ZITZVVOASA-N
|
PubChem Compound ID |
|
Target and Pathway |
Target(s) |
Coagulation factor IIa |
Target Info |
Inhibitor |
[1]
|
Coagulation factor Xa |
Target Info |
Inhibitor |
[1]
|
Squalene monooxygenase |
Target Info |
Inhibitor |
[2]
|
KEGG Pathway
|
Neuroactive ligand-receptor interaction
|
Complement and coagulation cascades
|
Regulation of actin cytoskeletonhsa04610:Complement and coagulation cascadessce00100:Steroid biosynthesis
|
Sesquiterpenoid and triterpenoid biosynthesis
|
Metabolic pathways
|
Biosynthesis of secondary metabolites
|
Biosynthesis of antibiotics
|
NetPath Pathway
|
TCR Signaling Pathway
|
PANTHER Pathway
|
Blood coagulationP00011:Blood coagulation
|
Pathway Interaction Database
|
Thrombin/protease-activated receptor (PAR) pathway
|
Angiopoietin receptor Tie2-mediated signaling
|
FOXA2 and FOXA3 transcription factor networks
|
PAR4-mediated thrombin signaling events
|
Syndecan-4-mediated signaling events
|
PAR1-mediated thrombin signaling eventsintegrin2_pathway:Beta2 integrin cell surface interactions
|
PathWhiz Pathway
|
Vitamin K Metabolism
|
CoagulationPW000562:CoagulationPW000050:Steroid Biosynthesis
|
Reactome
|
Intrinsic Pathway of Fibrin Clot Formation
|
Common Pathway of Fibrin Clot Formation
|
Gamma-carboxylation of protein precursors
|
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
|
Removal of aminoterminal propeptides from gamma-carboxylated proteins
|
Cell surface interactions at the vascular wall
|
Peptide ligand-binding receptors
|
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
|
G alpha (q) signalling events
|
Thrombin signalling through proteinase activated receptors (PARs)R-HSA-140834:Extrinsic Pathway of Fibrin Clot Formation
|
Removal of aminoterminal propeptides from gamma-carboxylated proteinsR-HSA-191273:Cholesterol biosynthesis
|
Activation of gene expression by SREBF (SREBP)
|
WikiPathways
|
Complement and Coagulation Cascades
|
Regulation of Actin Cytoskeleton
|
IL1 and megakaryotyces in obesity
|
Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
|
PTM: gamma carboxylation, hypusine formation and arylsulfatase activation
|
Blood Clotting Cascade
|
Gastrin-CREB signalling pathway via PKC and MAPK
|
Thrombin signalling through proteinase activated receptors (PARs)
|
Platelet Aggregation (Plug Formation)
|
GPCR ligand binding
|
GPCR downstream signaling
|
Formation of Fibrin Clot (Clotting Cascade)
|
Cell surface interactions at the vascular wall
|
Folate Metabolism
|
Vitamin B12 Metabolism
|
Selenium Micronutrient NetworkWP558:Complement and Coagulation Cascades
|
Human Complement System
|
References |
REF 1 | J Nat Prod. 1998 Nov;61(11):1356-60.Effects of tannins from Geum japonicum on the catalytic activity of thrombin and factor Xa of blood coagulation cascade. |
---|
REF 2 | J Nat Prod. 2001 Aug;64(8):1010-4.Ellagitannins and hexahydroxydiphenoyl esters as inhibitors of vertebrate squalene epoxidase. |